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 Reaction Rate Constants for FAC and NH2Cl.  Test compound (100 nM) removal was 35 
followed in buffered solutions (pH 8.7; 20 mM borate) with excess FAC (0.03-5.0 mM) or 36 
NH2Cl (0.3-3.0 mM).  NH2Cl solutions were prepared by adding stock solutions of FAC 37 
dropwise to excess NH4Cl (1.2:1 NH4Cl:HOCl).  Samples were quenched (45 mM Na2S2O3) 38 
prior to analysis.  Solution pH values and total chlorine concentrations did not change 39 
significantly over the course of the experiments.  Rate constants were calculated based on first-40 
order removal kinetics of the test compounds using measured steady-state total chlorine 41 
concentrations.  For ciprofloxacin, rate constants were measured at multiple NH2Cl and FAC 42 
concentrations to verify that observed ciprofloxacin transformation rates were not dependent on 43 
oxidant concentrations, but rather represented decay of the rapidly formed N-chlorinated 44 
ciprofloxacin intermediate as previously reported.
1
  First-order ciprofloxacin decay rates were 45 
therefore reported.  46 
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Reaction Rate Constants for the Chlorine Radical Anion, ·Cl2
-
.  Second-order rate 47 
constants for the reaction of test compounds with the dichlorine radical anion (·Cl2
-
) were 48 
measured by nanosecond transient absorption laser flash photolysis of solutions containing 49 
Na2S2O8 (25 mM), NaCl (100 mM), and test compounds (0-100 µM).  Excitation at 266 nm (8 ns 50 
FWHM, 10 Hz repetition rate) produced ·SO4
-
 that rapidly reacted with Cl
-
 to produce ·Cl2
-
 51 
(~1 µM).  Solution pH values ranged from 5.5 to 6.0.  The decay of ·Cl2
-
 was monitored at 340 52 
nm over 10 ms, and data was averaged over 10 shots.  ·Cl2
-
 decay was log-normalized and 53 
plotted versus test compound concentrations to determine second-order rate constants.  ·Cl2
-
 54 
decay was log-normalized and fit according to: 55 
A340 = fe
 + h                                                        (S1) 56 
where A(340) is the absorbance at 340 nm, f is the initial absorbance, g is the decay rate, and h is 57 
an offset due to a longer lived species formed after ·Cl2
-
 decay.
2
  ·Cl2
-
 decay rates were plotted 58 
versus test compound concentrations to determine second-order rate constants: 59 
g = k,∙[cmpd] + b                                                        (S2) 60 
where k,∙  is the second-order rate constant for the reaction of a test compound with ·Cl2
-
, 61 
[cmpd] is the test compound concentration, and b is the y-intercept that represents loss of ·Cl2
-
 62 
due to other reactions (e.g., quenching by H2O).  Under these conditions ·Cl is predicted to 63 
contribute less than 5% to measured second-order rate constants greater than 10
7
 M
-1
 s
-1
. 64 
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Chronoamperometric Experiments.  Chronoamperometric experiments were 65 
performed to verify direct electron transfer for compounds that underwent transformation in the 66 
absence of Cl
-
 and were soluble enough dissolve rapidly (i.e., ranitidine and cimetidine).  About 67 
5 mM of a solid test compound was added to a solution of Na2SO4 (20 mM) undergoing 68 
potentiostatic electrolysis (3.5 V cathode vs. anode), and the current response was observed.  A 69 
spike in the current upon test compound addition implied that the compound could be oxidized 70 
directly at the anode.
3,4
  The possibility that current increased due to a change in electrolyte 71 
strength was eliminated based on the current’s return to near baseline values after test compound 72 
oxidation was complete.  73 
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Transformation Product Identification.  Test compound transformation product 74 
formulae were calculated based on accurate masses and typically had a mass error of less than 2 75 
mDa (Table SI 2).  Transformation product halogen content was confirmed by characteristic 76 
isotopic patterns using the m/z+2, m/z+4, etc. peaks.  Isotopic peak ratios were typically within 77 
10% of theoretical values for the proposed formulae.  Transformation product structures were 78 
proposed based on the literature when possible (see bold references in Table SI 2), by comparing 79 
exact mass values and fragment ions.  In other cases, structures were proposed simply based on 80 
determined formulae.  In these cases, the exact position of certain functional groups (e.g., 81 
hydroxyl and chlorine) could not be determined.  When possible, proposed structures were 82 
verified with authentic standards, as specified in Table SI 2.  83 
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Analytical Methods. Dissolved organic carbon and dissolved inorganic carbon were 84 
measured by persulfate digestion using an Aurora TOC analyzer.
5
  NO3
-
, Cl
-
, PO4
3-
, SO4
2-
, and 85 
NH4
+
 were analyzed by ion chromatography (Dionex ICS 2000; AS19G anions, CS12A 86 
cations).
5
 87 
Test compounds were separated by an Acquity BEH C18 column (2.1x50 mm; 1.7 µm 88 
particles), eluted at 0.5 mL min
-1
 using acetonitrile and water with 0.1% formic acid and 1% 89 
acetonitrile.  The following gradient was used: 0 min, 5% acetonitrile; 0.2 min, 5% acetonitrile; 90 
3.2 min, 95% acetonitrile; 3.5 min, 95% acetonitrile; 3.6 min, 5% acetonitrile; 5 min, 5% 91 
acetonitrile.  Column temperature was held at 35 °C.  pCBA were detected by UV absorbance 92 
(270 nm).  Trace organic compounds were detected by positive electrospray ionization (ESI+) in 93 
resolution mode with a capillary voltage of 0.2 kV, a cone voltage of 50 V, and a source offset of 94 
80 V.  Source temperature was 120 °C and desolvation temperature was 400 °C.  Cone gas was 95 
40 L/h and desolvation gas was 800 L/h.  Scan time was 0.3 s in continuum mode.  A collision 96 
energy of 1.0 eV was used.  A second acquisition channel scanned collision energy from 0-30 eV 97 
for fragment identification.  Accurate mass values were corrected by the software using a leucine 98 
lock-mass. 99 
  100 
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Calculation of ·Cl2
-
 Reaction with Propranolol.  The fraction of ·Cl2
-
 reacting with 101 
propranolol (F∙#$,%&'%&()'$'$ in latrine wastewater (100 mg L
-1
 TOC) was calculated using ·Cl2
-
 102 
measured second-order reaction rate constants with propranolol (k∙#$,%&'%&()'$'$ and TOC 103 
(k∙#$,*+# to be:  104 
F∙#$,%&'%&()'$'$ =
k∙#$,%&'%&()'$'$[propranolol]
k∙#$,%&'%&()'$'$[propranolol] + k∙#$,*+#[TOC]
=
1.9x108	M
;	s
; ∗ 	1x10
>	M
1.9x108	M
;	s
; ∗ 	1x10
>	M + 1.9x10?	mg	L
;
;	s
; ∗ 	100	mg	L
;
= 0.0099 
  105 
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Test Compound Transformation Products.  Carbamazepine’s predominant 106 
transformation products were confirmed to be acridine, hydroxyacridine, and acridine-9-107 
carboxaldehyde (Table SI 2; Figures SI 12a and 13), based on authentic standards.  No 108 
chlorinated transformation products were identified during latrine wastewater or buffered Cl
-
 109 
solution electrolysis.  Transformation products were similar to those previously observed during 110 
oxidation and chlorination of carbamazepine.
6–10
 111 
Metoprolol and propranolol were predominantly transformed to chlorinated products that 112 
underwent further transformation to form products not detected by LCMS (Figures SI 12b,c and 113 
9).  Hydroxylated and multiply halogenated transformation products were also identified (Table 114 
SI 2).  Most metoprolol transformation products were identified previously during reverse 115 
osmosis retentate electrolysis
11
 or other treatment processes.
12,13
  Some propranolol 116 
transformation products observed in this study have been reported previously,
14–17
 but others 117 
have not, including the predominant chlorinated product (m/z 294.1276 amu; m/z+2 amu 118 
observed at ~33%). 119 
Identified ciprofloxacin transformation products were typically transformed at the 120 
piperazine group rather than chlorinated (Figures SI 12d, 13), as previously observed during 121 
ciprofloxacin reaction with FAC and ClO2.
1,18
   122 
Trimethoprim was transformed into a variety of hydroxylated and chlorinated 123 
transformation products, some of which have been identified during treatment using ferrate,
19
 124 
activated sludge,
20
 and FAC.
21
 125 
Only a few significant acetaminophen and cimetidine transformation products were 126 
observed (Figures SI 12f and 13), all of which are produced by reaction with FAC.
22–24
  As with 127 
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trimethoprim, different acetaminophen transformation products were observed in the absence of 128 
NH4
+
, including formation of dichlorinated acetaminophen. 129 
Ranitidine transformation products were chlorinated, demethylated, and oxidized, with 130 
the latter two transformations likely occurring at the furan group.
25
  Although a few of the 131 
identified products have previously been observed during chloramination of ranitidine,
25
 further 132 
work is needed to confirm transformation product structures (Table SI 2).  Many transformation 133 
products observed during latrine wastewater electrolysis were not observed during electrolysis of 134 
buffered Cl
-
 solutions (Figures SI 12g and 13; see main text). 135 
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Table SI 1.  Comparison of Measured Test Compound Reaction rates with HOCl and NH2Cl to Literature Values. 136 
 
137 
 
138 
 
139 
 
140 
 
141 
 
142 
 
143 
 
144 
 
145 
 
146 
 
147 
 
148 
 
149 
a
 Measured or calculated at pH 8.7.  
b 
FAC=[HOCl]+[OCl
-
].  
c
 n.a.: not available.  
d
 Calculated at pH 1.3 based on reported acid catalyzed reactions with HOCl.  150 
e
 First-order transformation rate is reported due to rapid quenching of the N-chlorinated ciprofloxacin intermediate by Na2S2O3.  
f
 Reaction rate between HOCl 151 
and the predominant fully protonated form of ciprofloxacin at pH 1.3.  
g
 Estimated based on complete removal within 10 s.152 
 
 
compound 
property
 
 
ABCD (M
-1
s
-1
)
 a,b 
measured               literature 
AEFGDH (M
-1
s
-1
)
 a
 
measured             literature 
ADHG (M
-1
s
-1
) 
 measured             literature 
carbamazepine 8.9(±1.0)x10
-2 
2.7×10
-2 (10)
 <3x10
-3
 n.a. 
c 
~1x10
5
 6.7×10
4
 
(10) 
metoprolol 1.9(±1.0)x10
-2 
2×10
-2  (16)
 <4x10
-3
 <0.1 
(16) 
~4x10
3
 0.6-1.4×10
3
 
(16,26) d
 
propranolol 0.27(±0.02) 0.3
 (16)
 <6x10
-3
 <0.1 
(16)
 ~2x10
5
 3.3×10
5
 
(16)  d
 
ciprofloxacin 5.6(±0.4)×10-4 s-1 
e
 7×10
-4
 s
-1 (1) e 
9×10
-4
 s
-1
 
e
 7×10
-4
 s
-1
 
(1) e
 ~6x10
3
 4.3×10
3 (1 ) f
 
trimethoprim 6.7(±0.2) 8 
(21) 
<1x10
-3
 negligible 
(21)
 ~3x10
6
 2x10
5
-2×10
6 (21)
 
acetaminophen 7.0(±0.4)×10
2
 0.7-1.4×10
2
 
(16,23,27) 
 0.9(±0.1) 1.1x10
-2 (16)
 ~3x10
4
 n.a.
 c
 
ranitidine >8×10
3
 n.a.
c 
11(±1) 12 
(25) 
~8x10
4
 n.a.
 c
 
cimetidine  >6.5×10
3 
>1×10
3
 
(24) g 
47(±1) 48 
(24)
 ~4x10
6
 n.a.
 c
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Table SI 2.  Test Compound Transformation Products (TPs). 153 
Parent 
Test 
compound 
 
TP m/z a 
(ID) 
Major 
Fragment 
ions m/z  
 
RT 
(min) 
 
Calculated 
Formula 
Mass 
Error 
(mDa) 
 
 
Proposed Molecular Ion Structure b 
 
 
Refs.c 
Carbamazepine 224.0715 
(Cbz 224) 
164.920, 
167.073, 
180.081, 
196.076  
0.58 C14H10NO2 0.3 
 
6,7
 
180.0812 d 
(Cbz 180) 
152.0621 1.17 C13H10N 0.3 
 
6,8
 
275.0800 
(Cbz 275) 
180.0800, 
210.0919, 
236.0712, 
253.0976 
1.58 C14H13NO5 0.6   
253.0974 d 
(Cbz 253) 
 1.59 C15H13N2O2 0.3 
 
6,10
 
196.0759 e 
(Cbz 196) 
167.073, 
180.0810 
1.65 C13H10NO 0.3 
 
6–9
 
208.0761 d 
(Cbz 208) 
152.062, 
180.082, 
196.0760 
2.07 C14H10NO 0.1 
 
8,9
 
Metoprolol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
226.1436 
(Met 226) 
116.1067, 
121.0636, 
149.0583 
0.82 C12H20NO3 0.7 
 
11,13
 
284.1853 
(Met 284) 
116.1063, 
226.1420, 
268.141 
0.85 C15H26NO4 0.9 
 
11,13
 
254.1393 
(Met 254) 
105.0692, 
151.0381, 
177.0540, 
212.0911, 
236.1275 
0.93 C13H20NO4 <0.1 
O
NH
OH
O
OH
 
 
238.1439 
(Met 238) 
105.0696, 
133.0642, 
149.0590 
161.0589, 
196.0962 
1.04 C13H20NO3 0.4 
O
NH
OH
O
 
12
 
282.1706 
(Met 282) 
105.0696, 
133.0642, 
149.0590 
161.0589, 
196.0962 
1.05 C15H24NO4 <0.1 
 
11
 
N
H
O
O
N
N
NH2 O
O
N
OH
N
H
O
N
O
O
NH2
OH
O
O
NH
OH
O
OH
O
NH
O
O
OH
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Parent 
Test 
compound 
 
TP m/z a 
(ID) 
Major 
Fragment 
ions m/z  
 
RT 
(min) 
 
Calculated 
Formula 
Mass 
Error 
(mDa) 
 
 
Proposed Molecular Ion Structure b 
 
 
Refs.c 
Metoprolol 
(cont.) 
302.1515 
(Met 302) 
98.0963, 
116.1066,  
167.0249, 
193.0407, 
260.1044, 
284.1411 
1.51 C15H25NO3Cl 0.8 
 
11
 
336.1121 
(Met 336) 
72.0817, 
98.0965, 
116.1064, 
276.0549,
294.0649, 
318.102 
1.62 C15H24NO3Cl2 1.2 
 
11
 
Propranolol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
276.1599 
(Pro 276) 
116.1074 1.0-
1.3 f 
 
C16H22NO3 <0.1 
O
NH
OH
OH
 
17
 
292.1545 
(Pro 292) 
116.107, 
123.092, 
150.128, 
274.144, 
272.128,  
1.29 C16H22NO4 0.4 
 
15
 
 
218.1180 
(Pro 218) 
116.1071,
183.0804 
 
1.45 C13H16NO2 0.1 
 
16
 
310.1210 
(Pro 310) 
72.0816, 
116.1071, 
135.1038, 
260.1653 
1.53 C16H21NO3Cl <0.1 
 
 
294.1276 
(Pro 294) 
150.128, 
260.165 
1.85 C16H21NO2Cl 1.5 
 
 
338.0739 
(Pro 338) 
116.1070,
182.0725,
217.0417 
1.94 C16H21NO2Br 1.7 
 
 
328.0868 
(Pro 328) 
72.0819, 
116.1068, 
219.1751 
1.98 C16H20NO2Cl2 0.3 
 
 
O
NH
OH
O
Cl
O
NH
OH
O
Cl
Cl
O
NH
OH
OH
OH
O
NH2
OH
O
NH
OH
Cl
OH
O
NH
OH
Cl
O
NH
OH
Br
O
NH
OH
Cl
Cl
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Parent 
Test 
compound 
 
TP m/z a 
(ID) 
Major 
Fragment 
ions m/z  
 
RT 
(min) 
 
Calculated 
Formula 
Mass 
Error 
(mDa) 
 
 
Proposed Molecular Ion Structure b 
 
 
Refs.c 
Ciprofloxacin 
 
 
 
 
 
 
 
 
 
 
306.1246 
(Cfx 306) 
217.0404, 
268.1077, 
288.1142 
1.09 C15H17N3O3F 0.8 
 
1,18
 
366.1012 
(Cfx 366) 
225.0213, 
245.1079, 
279.0695,
322.1108 
1.22 C17H18N3O3FCl 0.9 
 
1
 
362.1141 
(Cfx 362) 
344.1037 1.29 C17H17N3O5F 1.1 
 
18
 
291.0773 
(Cfx 291) 
245.0709, 
273.0671 
1.42 C14H12N2O4F 0.8 
 
 
263.0828 
(Cfx 263) 
204.032, 
245.0724 
1.49 C13H12N2O3F 0.4 
 
18
 
298.0287 
(Cfx 298) 
280.0184 1.63 C13H10NO4FCl 0.5  1 
289.0981 
(Cfx 289) 
271.0876 1.74 C15H14N2O3F 0.8 
 
 
Trimethoprim 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trimethoprim 
342.1327 
(Tmp 342) 
273.0978, 
307.1397 
0.98 C14H21N5O3Cl 0.6   
307.1391 
(Tmp 307) 
209.1644, 
212.0686, 
240.0634, 
258.0742, 
273.0975 
0.98 C14H19N4O4 1.5 
 
19
 
322.1508 
(Tmp 322) 
 1.04 C14H20N5O4 0.7   
325.1499 
(Tmp 325a) 
173.0813, 
219.0872, 
233.1043, 
293.1229 
1.05 C14H21N4O5 1.3 
 
20
 
343.1164 
(Tmp 343) 
181.0852 1.08 C14H20N4O4Cl 0.9 
 
 
NNH
NH2
O
OH
O
F
NN
NH
O
OH
O
F
Cl
NN
NH
O
OH
O
F
O
O
NNH
O
OH
O
F
O
NNH2
O
OH
O
F
NNCH2
O
OH
O
F
H
N
N
NH2
NH2
O
O
O
OH
N
NH
NH2
NH2
O
O
O
O
OH
N
NH
NH2
NH2
O
O
O
O
Cl
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Parent 
Test 
compound 
 
TP m/z a 
(ID) 
Major 
Fragment 
ions m/z  
 
RT 
(min) 
 
Calculated 
Formula 
Mass 
Error 
(mDa) 
 
 
Proposed Molecular Ion Structure b 
 
 
Refs.c 
(cont.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
359.1125 
(Tmp 359a) 
215.0465, 
240.0414, 
236.0905 
1.19 C14H20N4O5Cl 0.3 
 
 
323.1345 
(Tmp 323) 
 1.26 C14H19N4O5 1.0 
 
 
377.0773 
(Tmp 377) 
217.0435, 
236.0913, 
255.0416, 
257.0388, 
314.0898 
1.26 C14H19N4O4Cl2 1.0 
 
21
 
 
393.0719 
(Tmp 393) 
100.0503, 
126.0529, 
249.0075, 
270.0524 
1.32 C14H19N4O5Cl2 1.4 
N
NH
NH2
NH2
O
O
O
O
OH
2 Cl
 
 
325.1059 
(Tmp 325b) 
145.0267, 
271.0918, 
249.008 
1.39 C14H18N4O3Cl 0.8 
 
21
  
411.0391 
(Tmp 411) 
249.0080,
366.0616 
1.39 C14H18N4O4Cl3 0.3 
 
21
  
369.0558 
(Tmp 369) 
255.0886,
273.092, 
325.1078, 
339.0081 
1.42 C14H18N4O3Br 0.4 
 
 
359.0672 
(Tmp 359b) 
181.0854, 
199.097, 
289.0480, 
298.0371, 
329.0196 
1.55 C14H17N4O3Cl2 0.6 
 
21
 
 
403.0174 
(Tmp 403) 
140.0686, 
180.8981, 
257.1478, 
359.0669 
1.58 C14H17N4O3BrCl 0.1 
 
 
Acetaminophen 
 
 
 
 
 
186.0312 
(Ace 186) 
109.0515, 
144.0201, 
155.9838 
1.17 C8H9NO2Cl 1.0 
O
NH
OH Cl
 
22,23
 
219.9919 
(Ace 219) 
143.0123, 
177.9810 
1.42 C8H8NO2Cl2 1.3 
O
NH
OH Cl
Cl
 
22,23
 
Ranitidine 
 
 
 
 
338.0561 
(Rnt 338) 
109.0278,
186.0565, 
202.9997,
214.0240,
292.0612 
0.63 C11H17N3O5SCl 1.6 
NH
NH
SOH O
N
+
O
-
O
Cl, OH
 
25
 
N
NH
NH2
NH2
O
O
O
O
OH
Cl
N
N
NH2
NH2
O
O
O
OH
OH
N
NH
NH2
NH2
O
O
O
O
Cl
Cl
N
N
NH2
NH2
O
O
O
Cl
N
NH
NH2
NH2
O
O
O
O
Cl
2 Cl
N
N
NH2
NH2
O
O
O
Br
N
N
NH2
NH2
O
O
O
2 Cl
N
N
NH2
NH2
O
O
O
Cl, Br
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Parent 
Test 
compound 
 
TP m/z a 
(ID) 
Major 
Fragment 
ions m/z  
 
RT 
(min) 
 
Calculated 
Formula 
Mass 
Error 
(mDa) 
 
 
Proposed Molecular Ion Structure b 
 
 
Refs.c 
 
 
 
 
 
 
336.0419 
(Rnt 336) 
125.0600,
181.0201,
203.0023,
214.0259,
290.0497 
0.66 C11H15N3O5SCl 0.2 
NH
NH
SO
N
+
O
-
O
O
Cl, OH
 
 
364.1194 
(Rnt 364) 
109.0278, 
163.0854, 
189.1012, 
258.0579 
0.76 C13H23N5O3SCl 1.6 
NH
NH
SN
+
O
N
+
O
-
ONH2
Cl
 
25
 
335.0928 
(Rnt 335) 
 0.85 C12H20N4O3SCl 1.6 
NH
NH
SNH O
N
+
O
-
O
Cl
 
 
349.1083 
(Rnt 349) 
124.075, 
132.0438, 
164.0159, 
210.0092, 
223.0893 
0.88 C13H22N4O3SCl 1.8 
NH
NH
SN O
N
+
O
-
O
Cl
 
25
 
270.0903 
(Rnt 270) 
97.0759, 
165.1013, 
191.1167, 
224.0971 
1.02 C11H16N3O3S 0.9   
322.061 
(Rnt 322) 
165.0236, 
240.1152 
1.08 C11H17N3O4SCl 1.8 
NH
NH
SOH O
N
+
O
-
O
Cl
 
 
320.0459 
(Rnt 320) 
109.028, 
165.0238,
208.0392,
234.0191,
274.0529 
1.12 C11H15N3O4SCl 1.3 
NH
NH
SO O
N
+
O
-
O
Cl
 
 
294.12575 
(Rnt 294) 
109.0294, 
150.1284, 
177.0489, 
188.0054, 
275.053  
1.85 C13H25NO2SCl 3.7   
Cimetidine 
  
  
117.0210 
(Cmt 117) 
90.0104 0.53 C4H6N2Cl 1.0 Cl
N
NH
 
24
 
189.0435 
(Cmt 189) 
82.0403 1.06 C5H9N4O2S 1.1 
S N
O
O
N
NH
N
 
24
 
a
 Compounds with m/z ratios in bold exhibited isotopic patterns consistent with the halogen atoms specified in the 154 
calculated formula (i.e., m/z+2, m/z+4, etc. peaks).  
b
 Structure of  unprotonated TP.  Structure based on calculated 155 
formula, fragments, and literature.  
c 
References in bold proposed compound structure shown.  References in italics 156 
observed similar major fragment ions.  
d
 TP identity confirmed based on authentic standard retention time and mass 157 
spectrum.  
e
 Authentic acridone standard (ketone product shown) retention time differed by ~0.03 min and had 158 
different fragmentation pattern, suggesting that hydroxyacridone was formed during electrolysis.  
f
 Multiple peaks 159 
observed. 160 
  161 
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 162 
Figure SI 1.  Schematic of electrochemical reactor used in this study. 163 
  164 
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Figure SI 2.  Measured first-order rate constants for the reaction of ciprofloxacin with various 165 
concentrations of NH2Cl and FAC.  Error bars represent ± one standard deviation. 166 
S18 
 
 167 
Figure SI 3.  Pseudo-first order test compound electrolysis rates (k; top) and rates normalized for 168 
charge (k′; bottom).  Solutions were electrolyzed at an applied potential of 3.5 V in 0-75 mM 169 
NaCl solution buffered at pH 8.7 (20 mM borate).  Average current densities: 0 mM, 0.6 A L
-1
; 170 
15 mM, 0.7 A L
-1
; 30 mM, 0.9 A L
-1
; 75 mM, 1.3 A L
-1
.  FAC production rates: 15 mM, 171 
0.9 µM s
-1
; 30 mM, 1.6 µM s
-1
; 75 mM, 3 µM s
-1
.  Error bars represent ± one standard deviation.   172 
  173 
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 174 
Figure SI 4.  Test compound removal during electrolysis (3.5 V; 0.6 A L
-1
) in water buffered at 175 
pH 8.7 (20 mM borate). 176 
 177 
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Figure SI 5.  Current during addition of solid test compounds to solutions of Na2SO4 (20 mM) 179 
undergoing electrolysis (3.5 V).  Spikes in current upon test compound addition imply direct 180 
electron transfer from the compound. 181 
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 183 
Figure SI 6.  Calculated contributions of transformation mechanisms to test compound removal 184 
in latrine wastewater electrolyzed at 3.5 V (0.7 A L
-1
).  Ciprofloxacin and cimetidine removal 185 
rates were over-predicted by reaction with NH2Cl. 186 
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 187 
Figure SI 7.  Test compound removal during electrolysis (3.5 V; 0.9 A L
-1
) in 30 mM NaCl 188 
solution buffered at pH 8.7 (20 mM borate).  Inset: [FAC] ([HOCl]+[OCl
-
]) during electrolysis.  189 
Note that FAC concentrations plateaued after ~60 min due to FAC reduction on the cathode.
28
 190 
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 192 
Figure SI 8.  NH2Cl reduction in buffered solution (pH 8.7) on a stainless steel cathode 193 
(k=0.02 C
-1
).  The experiment was performed in an H cell with anodic and cathodic chambers 194 
separated by a Nafion membrane to prevent formation of chloramines at the anode. The cathodic 195 
potential was controlled at a similar potential to that observed during wastewater electrolysis 196 
(i.e., about -1.5 V vs. an Ag/AgCl/Sat. NaCl reference electrode; 10 mA).  [NH2Cl]0=1 mM.  197 
Migration of NH2Cl through the Nafion membrane was insignificant over the 2 hr experiment. 198 
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 199 
Figure SI 9.  Chloramine concentration during electrolysis of latrine wastewater at various 200 
applied potentials (3.0-4.0 V) and chloride concentrations (30 mM; 75 mM).  Average current 201 
densities: 3.0 V, 0.5 A L
-1
; 3.5 V, 0.7 A L
-1
; 4.0 V, 1.3 A L
-1
; 3.5 V 75 mM Cl
-
, 1.1 A L
-1
. 202 
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 203 
Figure SI 10.  Correlation between test compound pseudo-first order electrolysis rates (kelect; s
-1
) 204 
in latrine wastewater at an applied potential of 3.5 V and measured second-order reaction rates 205 
with ·Cl2
-
 (k·Cl2-; M
-1
 s
-1
).  ·Cl2
- 
reaction rates with compounds that were too slow to measure by 206 
flash photolysis (carbamazepine, ciprofloxacin, and acetaminophen) were assumed to be between 207 
10
6.5
 and 10
7.5
 M
-1
 s
-1
.  Error bars represent ± one standard deviation.   208 
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 210 
Figure SI 11.  Pseudo-first order test compound electrolysis rates normalized for charge (k′) in 211 
latrine wastewater with or without added Na2S2O3.  Solutions were electrolyzed at an applied 212 
potential of 3.5 V.  Average current densities: Wastewater, 0.7 A L
-1
; Wastewater+30 mM 213 
Na2S2O3, 0.9 A L
-1
.  Average chloramine concentration: Wastewater, 0.3 mM; Wastewater+30 214 
mM Na2S2O3, 0 mM.  Error bars represent ± one standard deviation. 215 
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 230 
Figure SI 12.  Maximum responses of predominant transformation product formed during 231 
electrolysis (entire bar) and final amount remaining at end of electrolysis cycle (cross-hatched 232 
portion).  Electrolysis cycle was 180 min.  Transformation product IDs represent the nominal 233 
mass to charge ratio for each compound.  Structures are proposed based on accurate mass to 234 
charge ratios, fragments, and transformation products reported in the literature.  Further 235 
transformation product information is given in Table SI 2. 236 
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Figure SI 13a.  Test compound transformation product formation during latrine wastewater 243 
electrolysis at 3.0 V.  Transformation product IDs represent the nominal mass to charge ratio for 244 
each compound.  Further transformation product information is given in Table SI 2. 245 
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Figure SI 13b.  Test compound transformation product formation during latrine wastewater 249 
electrolysis at 3.5 V.  Transformation product IDs represent the nominal mass to charge ratio for 250 
each compound.  Further transformation product information is given in Table SI 2. 251 
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Figure SI 13c.  Test compound transformation product formation during latrine wastewater 255 
electrolysis at 4.0 V.  Transformation product IDs represent the nominal mass to charge ratio for 256 
each compound.  Further transformation product information is given in Table SI 2. 257 
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 260 
Figure SI 13d.  Test compound transformation product formation during latrine wastewater 261 
electrolysis at 3.5 V with added NaCl.  Transformation product IDs represent the nominal mass 262 
to charge ratio for each compound.  Further transformation product information is given in Table 263 
SI 2.  264 
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Figure SI 13e.  Test compound transformation product formation during buffered Cl
-
 solution 268 
electrolysis.  Transformation product IDs represent the nominal mass to charge ratio for each 269 
compound.  Further transformation product information is given in Table SI 2.  270 
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